# XIFYRM
> **NDA218395** · New Drug Application · Sponsor: AZURITY · Approved 2025-06-05
## Drug
- **FDA Application Number:** NDA218395
- **Application type:** New Drug Application
- **Brand name:** XIFYRM
- **Generic name:** MELOXICAM
- **Active ingredients:** MELOXICAM
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** AZURITY
- **Manufacturer:** Azurity Pharmaceuticals, Inc.
- **First approval:** 2025-06-05
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218395)
---
*MORVS · CC0 1.0*